Prime Joint Support Formula by Isotonix - Single Bottle (45 Servings)
$75.5
Sold By: Luciano
As the body ages, many people experience joint discomfort. One option is to take a joint supplement to help promote overall bone and joint health. When looking at a joint supplement, there are three main ingredients found in most products on the market glucosamine, chondroitin and methylsulfonylmethane, more commonly referred to as MSM. The research on both chondroitin and MSM is very controversial. Chondroitin, for instance, has very poor absorption due to its high molecular weight. Also, one of chondroitin’s mechanisms is to increase the hyaluronic acid content of synovial fluid; while the new Prime™ Joint Support Formula by Isotonix directly provides hyaluronic acid. Hyaluronic acid plays an important role in tissue hydration, lubrication and cellular function. Likewise, research on MSM is not conclusive. In fact, it takes large quantities of MSM daily 2-6 grams to make a difference and see effects.* On the other hand, the research behind glucosamine is consistent and its benefits effective. Prime Joint Support Formula contains glucosamine, naturally produced by the body and a key component of cartilage. An aminomonosaccharide a combination of the amino acid — glutamine and a sugar — glucose , glucosamine is concentrated in joint cartilage, and has been scientifically proven to support healthy joint function and promote the normal production of synovial fluid, which lubricates your joints and regenerates cartilage.* The natural aging process affects everyone and proper exercise, sleep and supplementation are essential for healthy living. Prime Joint Support Formula also contains the powerful antioxidant Pycnogenol , which science has shown help maintain the body’s natural defenses by inhibiting metabolic responses associated with the normal aging process. *These statements have not been evaluated by the Food and Drug Administration. This product s is not intended to diagnose, treat, cure or prevent any disease.
Condition: New
